Sun Pharma has entered into a non-exclusive patent licensing agreement with Japanese pharmaceutical company, Takeda to introduce a novel Gastrointestinal Drug, Voltapraz (Vonoprazan) in India. Read more here: https://bit.ly/3xoMY99
Fantastic update! It's A Great Molecule . Happy to note that this Excellent Treatment Option has been Outlicensed to 2 Giant Indian Multinationals who will do Justice to this Innovative Medication to Majority of Indian Patients who need it . The Indian MNC will also Ensure Proper Access in A Co.pliant manner in line with the Values of Takeda . Congrats! All the Best Team SUN for Every Success
Happy to hear about the success of this project!😊 Recalling the day when this was the first new project assigned to me in my new role as a 'Project Manager' last year. Congratulations! to the team SUN PHARMA for the fast and great delivery of the novel product for the Indian patients. 👏👏👏
Congratulations to Sun Pharma and Takeda on this exciting partnership! Bringing Voltapraz to India is a major step forward in treating the estimated 15-30% of the population suffering from acid peptic disorders and reflux esophagitis. This innovative drug promises to improve the lives of millions of individuals across the country.
Great move, Sun Pharma👍Looking forward to the positive impact this will have on patient care🙌
Exciting news, SUN PHARMA! Looking forward to new innovative collaborations and studies.
Impressive growth!
sir i want job in microbiology department
Inspiring!
Impressive growth!
#Pharmaceutical Project Management, Quality Management System, Pharmaceutical Process Excellence
3moEvery step counts and matters on the ladder of success…To meet the vision…✌️✌️